| 2024/05/02 17:35:26 | |
|---|---|
| Price | |
| 363.10 EUR | |
| Difference | 3.51% (12.30) |
General attributes
| ISIN | NL0010832176 |
| Symbol | ARGX |
| Exchange | Euronext Brussels |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 21,579 EUR |
| Benchmark | AMSTERDAM EXCHANGES INDEX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 357.10 EUR |
| High | 364.50 EUR |
| Low | 353.80 EUR |
| Close (prev. day) | 350.80 EUR |
| VWAP | 361.324045 EUR |
| Volume (pcs) | 64,915 |
| Trading volume | 23,455,350.00 |
| Number of trades | 3,549 |
| Last size | 14 |
Futures and Options
| Related Futures | 23 |
| Related Options | - |
PDF Downloads
| Company report: ARGENX SE |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/05/02 17:35:26 | |
|---|---|
| Price | |
| 363.10 EUR | |
| Difference | 3.51% (12.30) |
General attributes
| ISIN | NL0010832176 |
| Symbol | ARGX |
| Exchange | Euronext Brussels |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 21,579 EUR |
| Benchmark | AMSTERDAM EXCHANGES INDEX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 357.10 EUR |
| High | 364.50 EUR |
| Low | 353.80 EUR |
| Close (prev. day) | 350.80 EUR |
| VWAP | 361.324045 EUR |
| Volume (pcs) | 64,915 |
| Trading volume | 23,455,350.00 |
| Number of trades | 3,549 |
| Last size | 14 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -21.64% | +0.78% | +51.04% |
| Perf (abs.) | -100.30 | +2.80 | +122.70 |
| Beta | 0.90 | 0.38 | 0.46 |
| Volatility | 58.96 | 52.63 | 42.65 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 351.58 EUR (39,787) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 353.61 EUR (47,834) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 359.50 EUR (63,996) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 401.60 EUR (61,939) |
| YTD High | date | 381.10 EUR (2024/02/28) |
| YTD Low | date | 322.50 EUR (2024/03/20) |
| 52 Weeks High | date | 494.10 EUR (2023/07/21) |
| 52 Weeks Low | date | 271.00 EUR (2023/12/20) |
All listings for ARGENX SE
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Vienna Stock Exchange | 2024/05/02 | 09:14 | 354.60 EUR | 0.03 | 4 |
| Tradegate | 2024/05/02 | 22:26 | 365.60 EUR | 0.02 | 7 |
| Stuttgart | 2024/05/02 | 16:27 | 362.70 EUR | 0.00 | 10 |
| Munich | 2024/05/02 | 08:10 | 356.00 EUR | 0.00 | 2 |
| London Stock Exchange European Trade Reporting | 2024/05/02 | 17:30 | 363.75 EUR | 0.20 | 1 |
| Frankfurt | 2024/05/02 | 08:16 | 353.20 EUR | 0.00 | 2 |
| FINRA other OTC Issues | 2024/03/21 | 14:54 | 383.74 USD | 0.08 | 2 |
| Euronext Milan MTF Trading After Hours | - | - | - | 0.00 | - |
| Euronext Brussels | 2024/05/02 | 17:35 | 363.10 EUR | 23.46 | 3,549 |
| Duesseldorf | 2024/05/02 | 08:12 | 353.40 EUR | 0.00 | 3 |
| Berlin | 2024/05/02 | 21:50 | 364.30 EUR | 0.00 | 18 |
Company Logo
Contact Details
| ARGENX SE |
| - - |
| Laarderhoogtweg 25 - 1101 EB Amsterdam |
| Telefon: +31-76-303-04-88 |
| Fax: + |
| E-mail: info@argenx.com |
PDF Downloads
| Company report: ARGENX SE | |
Company Profile
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Breda, the Netherlands. |
Members of Management Board
| Tim Van Hauwermeiren | Chairman of Managing Board |
| Andria Wilk | Member of Executive Committee |
| Arjen Lemmen | Member of Executive Committee |
| Beth DelGiacco | Member of Executive Committee |
| Filip Borgions | Member of Executive Committee |
| Karen Massey | Member of Executive Committee |
| Karl Gubitz | Member of Executive Committee |
| Luc Truyen | Member of Executive Committee |
| Malini Moorthy | Member of Executive Committee |
| Marc Schorpion | Member of Executive Committee |
| Peter Ulrichts | Member of Executive Committee |
Board of directors
| Peter K. M. Verhaeghe | Chairman of Supervisory Board |
| Ana Cespedes | Member of Supervisory Board |
| Joseph deBethizy | Member of Supervisory Board |
| Pamela Klein | Member of Supervisory Board |
| Anthony Adam Rosenberg | Member of Supervisory Board |
| Camilla Sylvest | Member of Supervisory Board |
| James Daly | Member of Supervisory Board |
| Steve Krognes | Member of Supervisory Board |